Neurocrine Biosciences (NBIX) Tops Q3 EPS by 75c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $155.64 -1.71%
EPS Growth %: -12.4%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -12.4%
Financial Fact:
Total other income: 1.55M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $0.97, $0.75 better than the analyst estimate of $0.22. Revenue for the quarter came in at $258.5 million versus the consensus estimate of $283.04 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies
- Dell’s earning report was bullish for Intel CPU demand, analyst says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
